After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...